Biotechnology
600 companies in this industry
Insider Buys (30d)
38
$9.98B
Insider Sells (30d)
153
$211.83M
Top Companies by Market Cap
VRTXVertex Pharmaceuticals Incorporated
$131.16BMRNAModerna, Inc.
$85.50BREGNRegeneron Pharmaceuticals, Inc.
$83.15BARGXargenx SE
$45.82BRVMDRevolution Medicines, Inc.
$39.42BALNYAlnylam Pharmaceuticals, Inc.
$30.46BROIVRoivant Sciences Ltd.
$26.81BUTHRUnited Therapeutics Corporation
$25.15BBNTXBioNTech SE
$24.56BINCYIncyte Corporation
$23.69BRecent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | ANIX | Anixa Biosciences, Inc. | KUMAR AMIT | director, officer: Chief Executive Officer | Buy | 5,000 | $3.17 | $15.8K |
| Oct 30, 2026 | OTLC | ONCOTELIC THERAPEUTCS INC | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | Buy | 1,356,990 | $0.02 | $23.5K |
| Oct 30, 2026 | RLAY | Relay Therapeutics, Inc. | Bergstrom Donald A | officer: President, R&D | Sell | 2,252 | $18.62 | $41.9K |
| Oct 30, 2026 | MAZE | Maze Therapeutics, Inc. | Dandekar Atul | officer: CSBO | Sell | 7,500 | $32.07 | $240.5K |
| Oct 30, 2026 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | officer: Chief Financial Officer | Sell | 1,469 | $18.62 | $27.4K |
| Oct 30, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $594.78 | $5.65M |
| Oct 30, 2026 | IMVT | Immunovant, Inc. | Girao Tiago | officer: Chief Financial Officer | Sell | 6,606 | $28.50 | $188.3K |
| Oct 30, 2026 | RLAY | Relay Therapeutics, Inc. | Rahmer Peter | officer: See remarks | Sell | 753 | $18.62 | $14.0K |
| Oct 30, 2026 | SNDX | Syndax Pharmaceuticals, Inc. | Podlesak Dennis | director | Sell | 8,000 | $14.21 | $113.7K |
| Oct 30, 2026 | RAPP | Rapport Therapeutics, Inc. Common Stock | HEALY JAMES | director | Buy | 969,480 | $21.00 | $20.36M |
| Oct 30, 2026 | ACAD | Acadia Pharmaceuticals Inc. | Schneyer Mark C. | officer: EVP, CHIEF FINANCIAL OFFICER | Sell | 3,321 | $20.88 | $69.3K |
| Oct 29, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $585.49 | $5.56M |
| Oct 29, 2026 | BOLD | Boundless Bio, Inc. | TANG KEVIN | 10 percent owner | Buy | 10,707 | $2.40 | $25.7K |
| Oct 29, 2026 | ACTU | Actuate Therapeutics Inc | SCHMITT DANIEL M | director, officer: President, CEO and Director | Buy | 211,266 | $0.39 | $81.7K |
| Oct 29, 2026 | ADPT | Adaptive Biotechnologies Corporation | RUBINSTEIN JULIE | officer: President and COO | Sell | 35,643 | $28.00 | $998.1K |
| Oct 28, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 8,083 | $588.24 | $4.75M |
| Oct 28, 2026 | RLYB | Rallybio Corporation | Lieber Jonathan I | officer: Chief Financial Officer | Sell | 599 | $16.04 | $9.6K |
| Oct 28, 2026 | RVMD | Revolution Medicines, Inc. | Mancini Anthony | officer: See Remarks | Sell | 2,310 | $186.99 | $431.9K |
| Oct 28, 2026 | LONA | LeonaBio, Inc. | Portman David J. | 10 percent owner | Buy | 3,149,470 | $3149.47 | $9.92B |
| Oct 28, 2026 | AGIO | Agios Pharmaceuticals, Inc. | Gheuens Sarah | officer: Chief Medical Officer | Sell | 7,866 | $37.69 | $296.5K |
| Oct 28, 2026 | XBIT | XBiotech Inc. | SIMARD JOHN | director, 10 percent owner: | Buy | 368,524 | $1.93 | $711.3K |
| Oct 27, 2026 | IRD | Opus Genetics, Inc. | Gagnon Robert E. | officer: Chief Financial Officer | Sell | 14,000 | $3.55 | $49.6K |
| Oct 27, 2026 | IRD | Opus Genetics, Inc. | SCHACHLE JOSEPH K | officer: Chief Operating Officer | Sell | 4,767 | $3.56 | $17.0K |
| Oct 27, 2026 | IRD | Opus Genetics, Inc. | Magrath George | director, officer: Chief Executive Officer | Sell | 9,591 | $3.59 | $34.4K |
| Oct 27, 2026 | SRRK | Scholar Rock Holding Corporation | AKKARAJU SRINIVAS | director | Buy | 289,470 | $41.45 | $12.00M |
| Oct 27, 2026 | NXTC | NextCure, Inc. | ADAR1 Capital Management, LLC | 10 percent owner | Buy | 10,851 | $4.95 | $53.7K |
| Oct 27, 2026 | IRD | Opus Genetics, Inc. | YERXA BENJAMIN R | director, officer: President | Sell | 33,189 | $3.54 | $117.4K |
| Oct 27, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $588.64 | $5.59M |
| Oct 27, 2026 | TWST | Twist Bioscience Corporation | Finn Patrick John | officer: President and COO | Sell | 2,245 | $134.59 | $302.2K |
| Oct 26, 2026 | EXOZ | eXoZymes, Inc. | Perriman Damien Alan | officer: Chief Commercial Officer | Sell | 3,729 | $5.21 | $19.4K |
| Oct 26, 2026 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | director, officer: CEO & President | Buy | 31,675 | $0.16 | $5.1K |
| Oct 26, 2026 | ANIX | Anixa Biosciences, Inc. | Titterton Lewis H jr | director | Buy | 8,000 | $2.98 | $23.8K |
| Oct 26, 2026 | BOLD | Boundless Bio, Inc. | TANG KEVIN | 10 percent owner | Buy | 21,640 | $2.39 | $51.6K |
| Oct 26, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $582.76 | $5.54M |
| Oct 26, 2026 | LITS | Lite Strategy, Inc. | Glover Nicholas | director | Buy | 2,000 | $6.28 | $12.6K |
| Oct 26, 2026 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10 percent owner | Buy | 87,801 | $1.81 | $158.6K |
| Oct 26, 2026 | ACRV | Acrivon Therapeutics, Inc. Common Stock | Miller Mary | officer: Chief Legal Officer | Sell | 513 | $1.84 | $943.92 |
| Oct 26, 2026 | KRRO | Korro Bio, Inc. | Lynx1 Capital Management LP | 10 percent owner | Buy | 79,809 | $11.09 | $884.8K |
| Oct 26, 2026 | ADPT | Adaptive Biotechnologies Corporation | RUBINSTEIN JULIE | officer: President and COO | Sell | 35,643 | $25.18 | $897.5K |
| Oct 23, 2026 | IMVT | Immunovant, Inc. | Stout Jay S | officer: Chief Technology Officer | Sell | 2,595 | $28.94 | $75.1K |
| Oct 23, 2026 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | director, officer: CEO & President | Buy | 31,250 | $0.16 | $5.1K |
| Oct 23, 2026 | RAPP | Rapport Therapeutics, Inc. Common Stock | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 2,210 | $29.16 | $64.4K |
| Oct 23, 2026 | PVLA | Palvella Therapeutics, Inc. | Goin Kathleen | officer: Chief Operating Officer | Sell | 4,313 | $124.58 | $537.3K |
| Oct 23, 2026 | KOD | Kodiak Sciences Inc. | BORGESON JOHN A. | officer: Chief Financial Officer | Sell | 28,000 | $89.82 | $2.52M |
| Oct 23, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 8,700 | $584.33 | $5.08M |
| Oct 23, 2026 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | officer: CHIEF FINANCIAL OFFICER | Sell | 36,342 | $1.34 | $48.7K |
| Oct 23, 2026 | RAPP | Rapport Therapeutics, Inc. Common Stock | Sanchez Ramiro | director | Buy | 3,600 | $27.35 | $98.5K |
| Oct 23, 2026 | AGIO | Agios Pharmaceuticals, Inc. | Gheuens Sarah | officer: Chief Medical Officer | Sell | 1,989 | $37.53 | $74.6K |
| Oct 22, 2026 | RAPP | Rapport Therapeutics, Inc. Common Stock | Silva Paul M | director | Buy | 3,680 | $27.08 | $99.6K |
| Oct 22, 2026 | RAPP | Rapport Therapeutics, Inc. Common Stock | Young Wendy B. | director | Buy | 3,789 | $26.39 | $100.0K |
Showing 1–50 of 191
1 / 4